Skip to Main Content

Author Details

Vincent Huang
Ontario Institute for Cancer Research
2016
21
18
PMIDPaper TitleJournal TitlePublished Year
34824250The telomere length landscape of prostate cancer.Nat Commun2021
32541955A robust benchmark for detection of germline large deletions and insertions.Nat Biotechnol2020
31954095Candidate Cancer Driver Mutations in Distal Regulatory Elements and Long-Range Chromatin Interaction Networks.Mol Cell2020
31974375Noncoding mutations target cis-regulatory elements of the FOXA1 plexus in prostate cancer.Nat Commun2020
32699374Author Correction: A robust benchmark for detection of germline large deletions and insertions.Nat Biotechnol2020
30685078Molecular Hallmarks of Multiparametric Magnetic Resonance Imaging Visibility in Prostate Cancer.Eur Urol2019
31735626Cistrome Partitioning Reveals Convergence of Somatic Mutations and Risk Variants on Master Transcription Regulators in Primary Prostate Tumors.Cancer Cell2019
31591588Genome-wide germline correlates of the epigenetic landscape of prostate cancer.Nat Med2019
30889379The Proteogenomic Landscape of Curable Prostate Cancer.Cancer Cell2019
30735634Widespread and Functional RNA Circularization in Localized Prostate Cancer.Cell2019
30643250Molecular landmarks of tumor hypoxia across cancer types.Nat Genet2019
29295717Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterations.BMC Cancer2018
30216362Prediction of early breast cancer patient survival using ensembles of hypoxia signatures.PLoS One2018
30400818Combining accurate tumor genome simulation with crowdsourcing to benchmark somatic structural variant detection.Genome Biol2018
30390622A comparative study of survival models for breast cancer prognostication revisited: the benefits of multi-gene models.BMC Bioinformatics2018
29681457The Evolutionary Landscape of Localized Prostate Cancers Drives Clinical Aggression.Cell2018
28067867Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectories.Nat Commun2017
28783165TMPRSS2-ERG fusion co-opts master transcription factors and activates NOTCH signaling in primary prostate cancer.Nat Genet2017
28068672Genomic hallmarks of localized, non-indolent prostate cancer.Nature2017
27902466Long non-coding RNA urothelial carcinoma associated 1 (UCA1) mediates radiation response in prostate cancer.Oncotarget2017
26472150Withaferin A suppresses the up-regulation of acetyl-coA carboxylase 1 and skin tumor formation in a skin carcinogenesis mouse model.Mol Carcinog2016
  • 1 - 21 of 21

Recommended Authors

Veracyte inc.
Career Start Year 2019
Number of shared co-authors 11
Case Western Reserve University
Career Start Year 2017
Number of shared co-authors 5
Caryl and Israel Englander Institute for Precision Medicine
Career Start Year 2017
Number of shared co-authors 5
Erasmus MC Cancer Institute
Career Start Year 2017
Number of shared co-authors 14
The Institute for Cancer Research
Career Start Year 2015
Number of shared co-authors 7
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 2014
Number of shared co-authors 2
Oncology R&D
Career Start Year 2013
Number of shared co-authors 6
GenomeDx Biosciences Inc.
Career Start Year 2012
Number of shared co-authors 26
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 2011
Number of shared co-authors 2
University of British Columbia
Career Start Year 2011
Number of shared co-authors 18
University of British Columbia
Career Start Year 2011
Number of shared co-authors 13
GenomeDx Biosciences Inc.
Career Start Year 2010
Number of shared co-authors 14
Bluestar Genomics Inc.
Career Start Year 2010
Number of shared co-authors 10
National Cancer Institute
Career Start Year 2010
Number of shared co-authors 6
University of Miami Miller School of Medicine/Sylvester Comprehensive Cancer Center
Career Start Year 2009
Number of shared co-authors 20
University of California-San Francisco
Career Start Year 2008
Number of shared co-authors 22
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 2007
Number of shared co-authors 4
University of British Columbia
Career Start Year 2007
Number of shared co-authors 25
University of Michigan ann arbor
Career Start Year 2007
Number of shared co-authors 18
Washington University in St Louis
Career Start Year 2006
Number of shared co-authors 28
Dana-Farber Cancer Institute
Career Start Year 2006
Number of shared co-authors 6
Veracyte Inc.
Career Start Year 2006
Number of shared co-authors 34
Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 2005
Number of shared co-authors 3
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 11
University of Washington, USA Institute for Stem Cell and Regenerative Medicine
Career Start Year 2003
Number of shared co-authors 5
Rogel Cancer Center, University of Michigan Medical School ann arbor
Career Start Year 2003
Number of shared co-authors 14
Institute for Computational Biomedicine
Career Start Year 2000
Number of shared co-authors 13
Johns Hopkins University School of Medicine
Career Start Year 1999
Number of shared co-authors 6
Michigan Center for Translational Pathology.
Career Start Year 1999
Number of shared co-authors 5
University of Michigan Medical School.
Career Start Year 1993
Number of shared co-authors 22

Collaborators

University of California los angeles
Co-authored papers 20
University of Toronto
Co-authored papers 13
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 12
University Health Network, University of Toronto
Co-authored papers 12
University of California los angeles
Co-authored papers 11
University of California los angeles
Co-authored papers 11
Ontario Institute for Cancer Research
Co-authored papers 8
Ontario Institute for Cancer Research
Co-authored papers 8
Ontario Institute for Cancer Research
Co-authored papers 7
Princess Margaret Cancer Research Centre
Co-authored papers 7
Ontario Institute for Cancer Research
Co-authored papers 6
Princess Margaret Cancer Center, University Health Network, University of Toronto
Co-authored papers 5
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 5
National Cancer Centre Singapore
Co-authored papers 5
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 5
University of California los angeles
Co-authored papers 5
University of California los angeles
Co-authored papers 5
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 5
Charles-Bruneau Cancer Center, Centre Hospitalier Universitaire (CHU) Sainte-Justine
Co-authored papers 4
University of Pennsylvania
Co-authored papers 4
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Co-authored papers 4
University of Texas MD Anderson Cancer Center
Co-authored papers 3
Ontario Institute for Cancer Research
Co-authored papers 3
CHU de Quebec-Universite Laval
Co-authored papers 3
Centre de recherche du CHU de Quebec-Universite Laval
Co-authored papers 3
University of British Columbia
Co-authored papers 3
Princess Margaret Cancer Research Centre
Co-authored papers 3
Ontario Institute for Cancer Research
Co-authored papers 3
University of Toronto
Co-authored papers 3
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Co-authored papers 3